In the era of digital trials, ensuring data integrity isn’t optional — it’s essential. ICH E6 (R3) redefines compliance for computerised systems — are you ready?
About this Guide
Stay ahead of GCP regulatory changes with our ICH E6 (R3) guide — designed for clinical trial sponsors, CROs, and validation experts.
The ICH E6 (R3) guideline introduces critical updates to Good Clinical Practice (GCP), focusing on computerised systems validation, data integrity, and risk-based system management. Published on January 6, 2025, and set for EMA adoption from July 23, 2025, this revision ensures clinical trials align with modern technology and regulatory compliance requirements.
Our expert guide breaks down the essential ICH E6 (R3) updates, including:
✅ Enhanced computerised systems requirements, with a dedicated chapter on system validation, user responsibilities, and operational controls.
✅ Risk-based computer system validation (CSV) approaches to ensure compliance while improving efficiency and data reliability.
✅ Advanced data integrity measures, covering audit trails, user authentication, cybersecurity, and disaster recovery planning.
✅ New system deployment guidelines, detailing approval processes, contingency planning, and user training for GCP compliance.
For a deeper dive into AIQSV, download the guide now.
🔍Why download this Guide?
This guide empowers your team to:
📌 Understand key changes in computerised system validation and data integrity requirements.
📌 Ensure GCP compliance and avoid regulatory setbacks.
📌 Implement risk-based validation strategies to streamline system qualification and deployment.
📌 Prepare your organisation for evolving GCP regulations and ICH E6 (R3) standards.
Who is this guide for?
This guide is essential for professionals working with clinical trial systems and validation, including:
🔹 Clinical trial sponsors and CROs
🔹 Regulatory affairs teams
🔹 IT specialists and system validation experts
🔹 Quality and compliance professionals
Ensure your clinical trials meet the latest ICH E6 (R3) standards with expert guidance on computerised systems validation.
View our other resources and company news
Case Study Driving Global QMS Harmonisation for a Pharmaceutical Company
Blog IT Quality Assurance in Regulated Life Sciences: Key Insights
General Practical compliance and inspection readiness for UK pharmaceutical quality systems
CSV Practical Guide to the EMA’s Draft EU GMP Revisions
Guide Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR
Blog AI for Pharmaceutical SOPs: Transforming Quality Management and Compliance
CAPA Strengthening CAPA & Exceptions Management
Blog EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance
Blog 